Roche holding ag stock

This means our website may not look and work as you would expect. Read more about browsers and how to update them here. Invest now.

Financial Times Close. Search the FT Search. Show more World link World. Show more US link US. Show more Companies link Companies. Show more Tech link Tech. Show more Markets link Markets.

Roche holding ag stock

Roche and its innovative U. Roche's immuno-oncology drug Tecentriq was launched third to market behind Bristol's Opdivo and Merck's Keytruda, raising questions about Roche's innovation. Morningstar brands and products. Investing Ideas. CHF As of Mar 8, pm Delayed Price Closed. Unlock our analysis with Morningstar Investor. Start Free Trial. Mar 8, Fair Value. Feb 1, Economic Moat Sgljd.

Show more US link US. Invest now. Market Closed - Swiss Exchange Other stock markets.

One can take advantage of the trading range to enter new positions. Add to a list Add to a list. To use this feature you must be a member. Market Closed - Swiss Exchange Other stock markets. Funds and ETFs. Last Hours! Enjoy this offer.

Roche and its innovative U. Roche's immuno-oncology drug Tecentriq was launched third to market behind Bristol's Opdivo and Merck's Keytruda, raising questions about Roche's innovation. Morningstar brands and products. Investing Ideas. CHF As of Mar 8, pm Delayed Price Closed. Unlock our analysis with Morningstar Investor. Start Free Trial.

Roche holding ag stock

CHF Key events shows relevant news articles on days with large price movements. Novartis AG. NOVN 0.

Big black dick rum

Year low : Annual div ADY 9. Deal now. Analysts' Consensus. Price CHF Annual div ADY 9. Morningstar brands and products. Latest news about Roche Holding AG. Roche's immuno-oncology drug Tecentriq was launched third to market behind Bristol's Opdivo and Merck's Keytruda, raising questions about Roche's innovation. Investing Ideas. You should independently check data before making any investment decision. Show more Tech link Tech. Roche is a Swiss biopharmaceutical and diagnostic company. This means our website may not look and work as you would expect.

Key events shows relevant news articles on days with large price movements.

The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in Ulf Mark Schneider td:not. Previous : 2. Dividend Yield Trailing 3. Show more Personal Finance link Personal Finance. Short selling activity Low. Show more Markets link Markets. Bears Roche's immuno-oncology drug Tecentriq was launched third to market behind Bristol's Opdivo and Merck's Keytruda, raising questions about Roche's innovation. Average volume Period 5 minutes 15 minutes 30 minutes 1 hour 1 day 1 week 1 month 1 year.